insulin drugs glp 1 receptor agaonist market GLP-1 Agonists Weight Loss Report, 2025-2030 GLP-1 Receptor Agonist Market Valued
Description
10.2337/db08-0958
Ready for a personal plan
doi: 10.1016/j.neulet.2015.12.007 196 SharmaMKJalewaJHolscherC
This work was supported by Logsynk Ltd
Animal studies have revealed embryofetal toxicity at supratherapeutic doses
